Anti-infective discovery is evolving with AI and robotics – learn how UK researchers aim to cut development time and improve ...

Welcome to the second installment of "Cancer and the Gut Microbiome: A Miniseries". Here, we focus on how the microbiome ...

This event will feature discussions on novel immune checkpoint inhibitors, personalized cancer vaccines and CAR T-Cell therapies. We will also address the challenges of translating basic research into ...

The Technology Networks team attended ASMS 2025 and spoke with Jim Gearing, who discusses the challenges that contaminant analysts face, and how Agilent are addressing these challenges by developing ...

At ASMS 2025, the Technology Networks team caught up with Jim Gearing, Associate Vice President of Marketing, Gas Phase ...

A new study shows that patients achieve good outcomes with a partial match drawn from the national public registry of donors ...

We spoke with the developers and manufacturers of the CRISPR gene therapy used to treat KJ Muldoon’s rare genetic condition, ...

Researchers from Mass General Brigham discovered that HBV does not cause liver inflammation or cancer on its own, but worsens ...

While chemotherapy can be lifesaving, it also damages DNA and leads to cognitive issues known as “chemo brain.” These effects ...

Researchers were able to prove for the first time that monocytes, important immune cells in the blood, react more strongly to ...

Researchers have discovered a potential treatment target that may re-energize dysfunctional or “exhausted” immune cells in ...

What’s missing from that are vast areas of the deep sea, particularly in the southern hemisphere. Invertebrates, despite ...